I thank the Secretary of State for his statement and for his compassion and care. Is he aware of any discussions on the continued alignment with the European Medicines Agency’s drug licensing process to ensure that our breast cancer patients,
and indeed all cancer patients, have access to the benefits of the European trials and the ability of UK citizens to participate in clinical trials? This is very important.